Alibaba Health Information Technology Limited

Symbol: ALBHF

PNK

0.4628

USD

Market price today

  • 355.7196

    P/E Ratio

  • -0.2817

    PEG Ratio

  • 7.44B

    MRK Cap

  • 0.00%

    DIV Yield

Alibaba Health Information Technology Limited (ALBHF) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.22%

Operating Profit Margin

0.01%

Net Profit Margin

0.03%

Return on Assets

0.01%

Return on Equity

0.01%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Pharmaceutical Retailers
CEO:Mr. Difan Shen
Full-time employees:1547
City:Causeway Bay
Address:Tower One
IPO:2018-07-20
CIK:

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.

General Outlook

When we look at how much money they make before expenses, they keep 0.222% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.009%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.029%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.005% return, is a testament to Alibaba Health Information Technology Limited's adeptness in optimizing resource deployment. Alibaba Health Information Technology Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.007%. Furthermore, the proficiency of Alibaba Health Information Technology Limited in capital utilization is underscored by a remarkable 0.002% return on capital employed.

Stock Prices

Alibaba Health Information Technology Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.44039, while its low point bottomed out at $0.4. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Alibaba Health Information Technology Limited's stock market.

Liquidity Ratios

Analyzing ALBHF liquidity ratios reveals its financial health of the firm. The current ratio of 301.00% gauges short-term asset coverage for liabilities. The quick ratio (244.01%) assesses immediate liquidity, while the cash ratio (224.52%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio301.00%
Quick Ratio244.01%
Cash Ratio224.52%

Profitability Ratios

ALBHF profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 3.03% underscores its earnings before tax deductions. The effective tax rate stands at 4.75%, revealing its tax efficiency. The net income per EBT, 95.74%, and the EBT per EBIT, 349.85%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 0.86%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin3.03%
Effective Tax Rate4.75%
Net Income per EBT95.74%
EBT per EBIT349.85%
EBIT per Revenue0.86%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.01, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 658.63% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding244
Days of Inventory Outstanding203
Operating Cycle258.22
Days of Payables Outstanding406
Cash Conversion Cycle-148
Receivables Turnover6.59
Payables Turnover0.90
Inventory Turnover1.80
Fixed Asset Turnover37.74
Asset Turnover0.19

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.01, and free cash flow per share, 0.01, depict cash generation on a per-share basis. The cash per share value, 0.90, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.03, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.01
Free Cash Flow per Share0.01
Cash per Share0.90
Operating Cash Flow Sales Ratio0.03
Free Cash Flow to Operating Cash Flow Ratio0.98
Cash Flow Coverage Ratio1.21
Short Term Coverage Ratio2.75
Capital Expenditure Coverage Ratio43.64
Dividend Paid and Capex Coverage Ratio43.64

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.41%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.01, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.31%, and total debt to capitalization, 0.55%, ratios shed light on its capital structure. An interest coverage of 49.59 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio0.41%
Debt Equity Ratio0.01
Long Term Debt to Capitalization0.31%
Total Debt to Capitalization0.55%
Interest Coverage49.59
Cash Flow to Debt Ratio1.21
Company Equity Multiplier1.33

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.98, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.04, reflects the portion of profit attributed to each share. The book value per share, 1.13, represents the net asset value distributed per share, while the tangible book value per share, 1.04, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.98
Net Income Per Share0.04
Book Value Per Share1.13
Tangible Book Value Per Share1.04
Shareholders Equity Per Share1.13
Interest Debt Per Share0.01

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 30.06%, indicates top-line expansion, while the gross profit growth, 38.79%, reveals profitability trends. EBIT growth, 162.24%, and operating income growth, 162.24%, offer insights into operational profitability progression. The net income growth, 300.86%, showcases bottom-line expansion, and the EPS growth, 303.05%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth30.06%
Gross Profit Growth38.79%
EBIT Growth162.24%
Operating Income Growth162.24%
Net Income Growth300.86%
EPS Growth303.05%
EPS Diluted Growth300.00%
Operating Cash Flow Growth-39.75%
Free Cash Flow Growth-38.97%
10-Year Revenue Growth per Share1781.07%
5-Year Revenue Growth per Share646.68%
3-Year Revenue Growth per Share146.80%
10-Year Operating CF Growth per Share1972.00%
5-Year Operating CF Growth per Share347.96%
3-Year Operating CF Growth per Share-61.23%
10-Year Net Income Growth per Share544.23%
5-Year Net Income Growth per Share439.81%
3-Year Net Income Growth per Share7267.23%
10-Year Shareholders Equity Growth per Share1344.00%
5-Year Shareholders Equity Growth per Share300.76%
3-Year Shareholders Equity Growth per Share154.84%
Receivables Growth12.17%
Inventory Growth35.62%
Asset Growth8.05%
Book Value per Share Growth7.63%
Debt Growth-42.55%
R&D Expense Growth-7.00%
SGA Expenses Growth-9.60%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 57,346,371,768.006, captures the company's total value, considering both debt and equity. Income quality, 0.46, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 2.53%, highlights investment in innovation. The ratio of intangibles to total assets, 5.40%, indicates the value of non-physical assets, and capex to operating cash flow, -2.32%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value57,346,371,768.006
Income Quality0.46
Sales General and Administrative to Revenue0.01
Research and Development to Revenue2.53%
Intangibles to Total Assets5.40%
Capex to Operating Cash Flow-2.32%
Capex to Revenue-0.02%
Capex to Depreciation-9.29%
Stock-Based Compensation to Revenue1.15%
Graham Number1.00
Return on Tangible Assets2.72%
Graham Net Net0.50
Working Capital9,476,346,000
Tangible Asset Value14,027,470,000
Net Current Asset Value9,313,568,000
Average Receivables547,386,000
Average Payables3,621,322,000
Average Inventory1,826,231,000
Days Sales Outstanding8
Days Payables Outstanding64
Days of Inventory On Hand36
ROIC3.14%
ROE0.04%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.56, and the price to book ratio, 2.56, reflect the market's valuation relative to the company's book value. The price to sales ratio, 12.26, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 469.45, and price to operating cash flows, 385.35, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.56
Price to Book Ratio2.56
Price to Sales Ratio12.26
Price Cash Flow Ratio385.35
Price Earnings to Growth Ratio-0.28
Enterprise Value Multiple1441.06
Price Fair Value2.56
Price to Operating Cash Flow Ratio385.35
Price to Free Cash Flows Ratio469.45
Price to Tangible Book Ratio4.49
Enterprise Value to Sales2.14
Enterprise Value Over EBITDA102.99
EV to Operating Cash Flow224.28
Earnings Yield0.78%
Free Cash Flow Yield0.37%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Alibaba Health Information Technology Limited (ALBHF) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 355.720 in 2024.

What is the ticker symbol of Alibaba Health Information Technology Limited stock?

The ticker symbol of Alibaba Health Information Technology Limited stock is ALBHF.

What is company IPO date?

IPO date of Alibaba Health Information Technology Limited is 2018-07-20.

What is company current share price?

Current share price is 0.463 USD.

What is stock market cap today?

The market cap of stock today is 7444131482.000.

What is PEG ratio in 2024?

The current -0.282 is -0.282 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1547.